In silico discovery of novel Retinoic Acid Receptor agonist structures
BACKGROUND: Several Retinoic Acid Receptors (RAR) agonists have therapeutic activity against a variety of cancer types; however, unacceptable toxicity profiles have hindered the development of drugs. RAR agonists presenting novel structural and chemical features could therefore open new avenues for...
Na minha lista:
| Publicado no: | BMC Struct Biol |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2001
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC32304/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11405897/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1472-6807-1-1 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|